Emergent Biosolutions INC (F/K/A Adapt Pharma INC )

Cutting-edge treatments for patients with special medical conditions

Based in PA

🤖

AI Overview

With $130K in lobbying spend across 8 quarterly filings, Emergent Biosolutions INC (F/K/A Adapt Pharma INC ) is an active lobbying client. Their lobbying covers 1 issue area. Active from 2018 to 2019.

$130K

Total Spend

Years Active

Firms Hired

Lobbyists Deployed

Issues Lobbied

Spending Trend

View as table

Year	Lobbying Spend
2018	$90K
2019	$40K

Issues Lobbied

Health Issues

Lobbying Firms

Burrell International Group LLC

Lobbyists

Deborah Burrell

What They Lobby About

These are actual descriptions from their quarterly lobbying disclosure filings, summarizing what they lobbied Congress and federal agencies about.Issue areas: Health Issues

•Opioid and heroin addiction legislation, Naloxone access.

•House and Senate Opioid Packages:
•H.R.6 - 115th Congress (2017-2018) SUPPORT for Patients and Communities Act;
•S.3120 - 115th Congress (2017-2018) HEAL Act of 2018;
•H.R.5925 - 115th Congress (2017-2

•HR 6, Labor HHS Appropriations;
•CARA 2.0;
•POWER Act;
•Naloxone access provisions, generally;
•Opioid Package, issues relating to: naloxone access, coprescribing/opioid prescribing guidelines,
•Judiciar

•NDAA - provisions related to biological and chemical defense
•Opioid and heroin addiction legislation, Naloxone access, coprescribing/opioid prescribing guidelines